Published work on intranasal peptide delivery (for insulin analogs, calcitonin, and oxytocin) demonstrates that bioavailability for this size class without enhancers is typically in the low single-digit percent range, though these data are from different peptides with different charge profiles
BPC-157 is not approved by the FDA or any regulatory agency for human use
TB-500 is a synthetic fragment of thymosin 4 (the Ac-LKKTETQ motif), while BPC-157 is a gastric-derived pentadecapeptide
The documented per-dose amounts (150 mcg from the 10 mg vial
It extends the half-life of your natural GHRH signaling, creating a sustained elevation in GH pulsatility rather than a single spike
Understanding AOD 9604: The Science Behind the Solution AOD 9604, short for "Advanced Obesity Drug," is a modified fragment of human growth hormone (HGH) specifically engineered to target fat metabolism.Unlike traditional HGH treatments, AOD 9604 focuses exclusively on fat burning without impacting blood sugar levels or cell growth